Table 4: Baseline and treatment characteristics of chronic urticaria patients on standard dose and greater than standard dose of Omalizumab.

- Standard Dose Greater than Standard Dose
Number of patients 134 14
Dose (mg) 300 450 (N=13)
600 (N=1)
M/F 45/89 5/9
Mean age (years) 35.9 36.1
Mean baseline IgE levels (kU/L) 453.7
(N=92)		 104.4
(N=7)